N2 non‐thermal atmospheric pressure plasma promotes wound healing in vitro and in vivo: Potential modulation of adhesion molecules and matrix metalloproteinase‐9

Advances in physics and biology have made it possible to apply non‐thermal atmospheric pressure plasma (NTP) in the biomedical field. Although accumulating evidence suggests that NTP has various medicinal effects, such as facilitating skin wound healing on exposed tissue while minimizing undesirable...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental dermatology 2017-02, Vol.26 (2), p.163-170
Hauptverfasser: Kang, Sung Un, Choi, Jae Won, Chang, Jae Won, Kim, Kang il, Kim, Yeon Soo, Park, Ju Kyeong, Kim, Yang Eun, Lee, Yun Sang, Yang, Sang Sik, Kim, Chul‐Ho
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Advances in physics and biology have made it possible to apply non‐thermal atmospheric pressure plasma (NTP) in the biomedical field. Although accumulating evidence suggests that NTP has various medicinal effects, such as facilitating skin wound healing on exposed tissue while minimizing undesirable tissue damage, the underlying molecular mechanisms are not fully understood. In this study, NTP generated from N2 optimized wound healing in the scratch wound healing assay. In addition, matrix metalloproteinase (MMP)‐9 expression and enzyme activity increased and the urokinase‐type plasminogen activator (uPA) system was activated after NTP treatment. We also showed that NTP treatment increased Slug and TCF8/ZEB1 expression and decreased that of E‐cadherin, suggesting induction of the epithelial‐to‐mesenchymal transition (EMT). The effect of N2 NTP was verified on rat wound model. Taken together, these results suggest that N2 NTP promotes wound healing by inducing the EMT and activating the MMP‐9/uPA system. These findings show the therapeutic potential of NTP for skin wound healing.
ISSN:0906-6705
1600-0625
DOI:10.1111/exd.13229